Literature DB >> 3839351

Atracurium-receptor kinetics: simple behavior from a mixture.

Y Amaki, B E Waud, D R Waud.   

Abstract

The apparent atracurium-receptor dissociation constant was assayed at the end-plate region of isolated guinea pig muscles. In a parallel series of experiments, the ED50 for producing neuromuscular block in the lumbrical muscle was also determined. The ratio of these two values was similar to the ratio found with classical competitive neuromuscular blocking agents like d-tubocurarine or pancuronium. We conclude that the commercial preparation of atracurium, though a mixture containing isomers of different configurations, behaves kinetically in a manner indistinguishable from what would be expected from a single substance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839351

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium.

Authors:  V Nigrovic; J Gaspari; M Banoub
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 2.  Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 3.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

4.  Competition between acetylcholine and a nondepolarizing muscle relaxant for binding to the postsynaptic receptors at the motor end plate: simulation of twitch strength and neuromuscular block.

Authors:  Vladimir Nigrovic; Anton Amann
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-02       Impact factor: 2.745

5.  Volume of the effect compartment in simulations of neuromuscular block.

Authors:  Vladimir Nigrovic; Johannes H Proost; Anton Amann; Shashi B Bhatt
Journal:  Theor Biol Med Model       Date:  2005-10-03       Impact factor: 2.432

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.